Last reviewed · How we verify

NCT04104815

GI Tolerance and Acceptability of a New Thickener

Withdrawn NA Last updated 17 March 2021
What this trial tests

NA trial testing Experimental Thickener in Gastro-intestinal Tolerance. Withdrawn.

Timeline
5 February 2021
Primary endpoint
5 February 2021
5 February 2021

Quick facts

Lead sponsorAbbott Nutrition
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Start date5 February 2021
Primary completion5 February 2021
Estimated completion5 February 2021

Drugs / interventions tested

Conditions studied

Sponsor

Abbott Nutrition — full company profile →

Who can join

18 and older, any sex, with Gastro-intestinal Tolerance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The current study is designed to evaluate the gastrointestinal tolerance and acceptability of a new thickener for dysphagia patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Abbott Nutrition trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04104815.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing